Understanding Steven Horwitz
Exploring Steven Horwitz reveals several interesting facts. ASH Meeting on Hematologic Maligancies speaker
Key Takeaways about Steven Horwitz
- September 2018: Brentuximab vedotin (ADCETRIS®) has recently been approved as a treatment for cutaneous lymphoma.
- Interview with
- What is the most important highlight from TCLF 2015? Interviewed at the 7th Annual T-cell Lymphoma Forum held January 29-31, ...
- Has there been anything presented at TCLF 2015 that has been surprising? Interviewed at the 7th Annual T-cell Lymphoma ...
- What message do you have for young investigators thinking of attending future T-cell Lymphoma Forums? Interviewed at the 7th ...
Detailed Analysis of Steven Horwitz
Welcome Video by Dr. Steven Horwitz Does TCLF present opportunities unavailable at larger conferences? Interviewed at the 7th Annual T-cell Lymphoma Forum held ...
Steven Horwitz
Stay tuned for more updates related to Steven Horwitz.